异丙酚输注相关不良事件的研究进展

www.yongyao.net　　2009-8-12 10:21:12　　来源：　　责任编辑：

分享到：

参　考　文　献
1. Reich DL, Hossain S, KrolM, Baez B, Patel P, Bernstein A,Bodian CA. Anesth Analg. Predictors of hypotension after induction of general anesthesia. 2005,Sep: 101 (3) : 622 - 8.
2. Bendel S, Ruokonen E, Polonen P, Uusaro A.Propofol causes more hypotension than etomidate in patients with severe aortic stenosis: a double -blind, randomized study comparing p ropofol and etomidate. Acta Anaesthesiol Scand. 2007, Mar; 51(3) : 284 - 9.
3. M. L im, FRCA, and P. E11ahee. Recommendations for Postinduction Hypotension: Are They Supported by the Evidence Anesth Analg 2006, 102: 1589 -1590.
4. 肖晓山,刘瑛,等. 异丙酚不同注药速度对呼吸循环的影响. 临床麻醉学杂志. 1999, 15: 122.
5. BelindaM. Schramm, MB BS, FANZCA, and Beverley A. Orser, MD PhDo Dystonic Reaction to Propofol Attenuated by Benztrop ine ( Cogentin ).Anesth Analg 2002, 94: 1237 -1240.
6. Buckley PM. Propofol in patients needing long - term sedation in intensive care . an assessment of the development of tolerance. A p ilot study . Intensive care
med 1997 sep; 23 (9) : 969 - 74.
7. B ird H, Brim V . Propofol and postop retive pancreatitis. Anaesthesia 2000, 55: 506 - 7.
8. Gottschling S, Larsen R, Meyer S, Graf N, Reinhard H1Acute pancreafitis induced by sho - ternap ropofol administration. Paediatr Anaesth. 2005Nov; 15 (11) : 1006 - 8.
9. Kelbel l, Weiss M. Anaesthetics and immune function. CurrOp in Anaesthesiol 2001, 14 (6) : 685 - 91
10. Helmy SA, A1 - Attiyab IU. The immunomodulatory effects of p rolonged intravenous of p ropofol versusmidazolam in critically ill surgical paients. Anaesthesia, 2001, 56 (1) ; 4 - 8.
11. Schulze HJ , Wendel HPet al. Effects of the p ropofol combination anesthesia on the intrinsic blood - clotting system. Immunopharmacology. 1999, Sep; 43 (2
- 3) : 141 - 4.
12. Kimis. S vesta. PharmD Bcp s. The Annals of pharmaco Therapy. 2006 Ap ril ; 40 (5) : 980 - 982.
13. Bustamante SE, Appachi E. Acute pancreatitis after anesthesia with p ropofol in a child with glycogen storage disease type IA. Paediatr Anaesth. 2006Jun; 16 (6) : 680 - 3.
14. Wolf A, Weir P, Segar P, Stone J , Shield J. Impaired fatty acid oxidation in p ropofol infusion syndrome. Lancet 2001, 357: 606 - 7.
15. 黄雄庆,陈秉学,等. 异丙酚对大鼠心肌β受体的影响. 中华麻醉学杂志, 1998, 18: 741 - 743.
16. Kumar MA, Urrutia VC, Thomas CE, Abou -Khaled KJ, Schwartzman RJ, The syndrome of irreversible acidosis after p rolonged p ropofol infusion.Neurocrit Care. 2005, 3 (3) : 257 - 9.
17. Huang CL, Wang YP, Cheng YJ , et al. The effect of carrier intravenous fiud speed onm the injectionpain of p ropofol. Anesth Analg, 1995, 81: 1087 -
1088.
18. P PicardMR Tramer. Prevention of pain on injection with p ropofol: a quantitative systematic review. Anesthesia and Analgesia 2000, 90: 963 - 969.
19. VictorM. Montori, MD, MSc; B ruce R. Bistrian,MD, PhD; M. MollyMcMahon, MD, Hyperglycemia in Acutely Iii Patients. JAMA. 2002, 288: 2167
- 2169.
20. Thomp son KA, Goodale DB. The recent development of p ropofol (D IP EIVANT). Intensive CareMed 2000; 26 ( Supp l. 4) : S400 - 4.
21. Claude A. Trépanier, MD FRCPC and Martin R.Lessard, MD FRCPC. Propofol and the risk of t4ansmission of infection. Canadian Journal ofAnesthesia2003; 50: 533 - 537.
22. J. R. Sneyd. Propofol and nausea and vowiting.B ritish Journal of Anaesthesia 2004, 93 ( 5) : 725 -736.